Kite Pharma

Kite Pharma is a biotechnology company specializing in developing advanced cancer treatments using a patient's own immune cells. They engineer these cells, called T-cells, to better recognize and attack cancer more effectively. This personalized approach, known as CAR-T cell therapy, offers new hope for certain blood cancers like lymphoma and leukemia, especially in cases where traditional treatments have failed. Kite Pharma’s innovations aim to improve outcomes and bring more targeted, effective immunotherapies to patients, making it a leader in the rapidly evolving field of cancer immunotherapy.